Lista de obras - Fares Al-Ejeh - Dominio Público Uruguay

'Omics Approaches in Breast Cancer Research and Clinical Practice

artículo científico publicado en 2016

A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancer

A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution

artículo científico publicado en 2009

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

artículo científico publicado en 2018

APOMAB, a La-specific monoclonal antibody, detects the apoptotic tumor response to life-prolonging and DNA-damaging chemotherapy

artículo científico publicado en 2009

Abstract LB-116: Cep55, a master regulator of cytokinesis in breast cancer pathogenesis

Abstract P5-04-17: From transcriptome meta-analysis to targeted therapies in triple negative breast cancer

Abstract P6-09-47: The development of personalized diagnostic tests and therapeutic strategies in breast cancer

article

Abstract P6-10-06: Rational combination therapy against triple-negative breast cancer

Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges

scientific article published on 24 November 2010

Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study

Breast cancer stem cells: treatment resistance and therapeutic opportunities

scientific article published on 10 February 2011

Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient

artículo científico publicado en 2018

Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumors

artículo científico publicado en 2009

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases

scientific article published on 31 July 2020

Differential gene expression of tumor-infiltrating CD8+ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis

scientific article published on 01 September 2020

Eph family co-expression patterns define unique clusters predictive of cancer phenotype

artículo científico publicado en 2014

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia

artículo científico publicado en 2015

EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma

artículo científico publicado en 2018

EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia

artículo científico publicado en 2016

EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.

artículo científico publicado en 2013

Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer

scientific article published on 02 May 2022

Essential developmental, genomic stability, and tumour suppressor functions of the mouse orthologue of hSSB1/NABP2.

artículo científico publicado en 2013

G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis

artículo científico publicado en 2017

Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma

artículo científico publicado en 2014

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

article

Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes

artículo científico publicado en 2010

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

artículo científico publicado en 2017

Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor Cells

artículo científico publicado en 2009

In vivo targeting of dead tumor cells in a murine tumor model using a monoclonal antibody specific for the La autoantigen

artículo científico publicado en 2007

Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance

artículo científico

Kinetic analysis of plasminogen activator inhibitor type-2: urokinase complex formation and subsequent internalisation by carcinoma cell lines

artículo científico publicado en 2004

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer

artículo científico publicado en 2014

Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage.

artículo científico

Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer

artículo científico publicado en 2016

MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments

artículo científico publicado en 2015

MITF and BRN2 contribute to metastatic growth after dissemination of melanoma

artículo científico publicado en 2017

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer

artículo científico publicado en 2014

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer.

artículo científico publicado en 2014

Molecular Diagnostics: Translation from Discovery to Clinical Practice

Multidimensional phenotyping of breast cancer cell lines to guide preclinical research

artículo científico publicado en 2017

Multifunctional core-shell magnetic cisplatin nanocarriers

artículo científico publicado en 2009

Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11.

artículo científico publicado en 2011

Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome

artículo científico publicado en 2011

Nutlin-3a is a potential therapeutic for ewing sarcoma

artículo científico publicado en 2010

Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-β-induced collagen expression in hepatic stellate cells.

artículo científico publicado en 2019

PDTB-19. EphA RECEPTOR TYROSINE KINASES AS TARGETS FOR THERAPY IN PAEDIATRIC MEDULLOBLASTOMA

Plasma functionalized PDMS microfluidic chips: towards point-of-care capture of circulating tumor cells

Postchemotherapy and Tumor-Selective Targeting with the La-Specific DAB4 Monoclonal Antibody Relates to Apoptotic Cell Clearance

artículo científico publicado en 2014

Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma

artículo científico publicado en 2007

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

artículo científico publicado en 2022

Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment.

artículo científico publicado en 2019

Quinazolinone derivatives as inhibitors of homologous recombinase RAD51.

artículo científico publicado en 2017

RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy

artículo científico publicado en 2016

Rad51 supports triple negative breast cancer metastasis

artículo científico publicado en 2014

SCF-FBXO31 E3 ligase targets DNA replication factor Cdt1 for proteolysis in the G2 phase of cell cycle to prevent re-replication

artículo científico publicado en 2014

Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer

Ssb1 and Ssb2 cooperate to regulate mouse hematopoietic stem and progenitor cells by resolving replicative stress.

artículo científico publicado en 2017

The La Autoantigen Is a Malignancy-Associated Cell Death Target That Is Induced by DNA-Damaging Drugs

artículo científico publicado en 2007

The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®.

artículo científico publicado en 2014

Tocotrienol as a potential anticancer agent

artículo científico publicado en 2011

Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor

artículo científico publicado en 2013

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib

artículo científico publicado en 2015

Lista de obras de Fares Al-Ejeh

'Omics Approaches in Breast Cancer Research and Clinical Practice

A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancer

A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

APOMAB, a La-specific monoclonal antibody, detects the apoptotic tumor response to life-prolonging and DNA-damaging chemotherapy

Abstract LB-116: Cep55, a master regulator of cytokinesis in breast cancer pathogenesis

Abstract P5-04-17: From transcriptome meta-analysis to targeted therapies in triple negative breast cancer

Abstract P6-09-47: The development of personalized diagnostic tests and therapeutic strategies in breast cancer

Abstract P6-10-06: Rational combination therapy against triple-negative breast cancer

Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges

Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study

Breast cancer stem cells: treatment resistance and therapeutic opportunities

Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient

Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumors

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases

Differential gene expression of tumor-infiltrating CD8+ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis

Eph family co-expression patterns define unique clusters predictive of cancer phenotype

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia

EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma

EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia

EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.

Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer

Essential developmental, genomic stability, and tumour suppressor functions of the mouse orthologue of hSSB1/NABP2.

G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis

Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor Cells

In vivo targeting of dead tumor cells in a murine tumor model using a monoclonal antibody specific for the La autoantigen

Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance

Kinetic analysis of plasminogen activator inhibitor type-2: urokinase complex formation and subsequent internalisation by carcinoma cell lines

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer

Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage.

Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer

MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments

MITF and BRN2 contribute to metastatic growth after dissemination of melanoma

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer.

Molecular Diagnostics: Translation from Discovery to Clinical Practice

Multidimensional phenotyping of breast cancer cell lines to guide preclinical research

Multifunctional core-shell magnetic cisplatin nanocarriers

Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11.

Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome

Nutlin-3a is a potential therapeutic for ewing sarcoma

Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-β-induced collagen expression in hepatic stellate cells.

PDTB-19. EphA RECEPTOR TYROSINE KINASES AS TARGETS FOR THERAPY IN PAEDIATRIC MEDULLOBLASTOMA

Plasma functionalized PDMS microfluidic chips: towards point-of-care capture of circulating tumor cells

Postchemotherapy and Tumor-Selective Targeting with the La-Specific DAB4 Monoclonal Antibody Relates to Apoptotic Cell Clearance

Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment.

Quinazolinone derivatives as inhibitors of homologous recombinase RAD51.

RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy

Rad51 supports triple negative breast cancer metastasis

SCF-FBXO31 E3 ligase targets DNA replication factor Cdt1 for proteolysis in the G2 phase of cell cycle to prevent re-replication

Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer

Ssb1 and Ssb2 cooperate to regulate mouse hematopoietic stem and progenitor cells by resolving replicative stress.

The La Autoantigen Is a Malignancy-Associated Cell Death Target That Is Induced by DNA-Damaging Drugs

The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®.

Tocotrienol as a potential anticancer agent

Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib